ClinicalTrials.Veeva

Menu

Digitally-Enabled Weight Management Program on T2DM

Abbott logo

Abbott

Status

Completed

Conditions

Type 2 Diabetes
Weight Change, Body

Treatments

Other: Option 1
Other: Option 2
Other: Option 3

Study type

Observational

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

The study (known as clinical audit in UK) will observe and report on a digitally-enabled structured weight management program including use of a meal replacement on clinical and economic outcomes for community-dwelling adults living with type 2 diabetes.

Enrollment

217 patients

Sex

All

Ages

20 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Have a clinical diagnosis of T2DM within the last 6 years
  2. Aged 20 - 70 years
  3. Have a BMI ≥ 27 kg/m2
  4. HbA1c ≥ 48 mmol/mol (≥ 42mmol/mol if prescribed glucose-lowering agents)
  5. Have access to the internet and a computer, smartphone or tablet
  6. Ability to read and understand English
  7. Willing to provide individual consent

Exclusion criteria

  1. Current insulin use
  2. More than two anti-hyperglycemic agents prescribed
  3. Recent routine HbA1c ≥ 90 mmol/mol
  4. Diagnosed with moderate or severe frailty
  5. Diagnosed eating disorder or purging
  6. Unable or unwilling to tolerate soy/milk-based meal replacements
  7. Myocardial infarction within last 6 months
  8. Recent eGFR <30 ml/min/1.73 m2
  9. Prescribed SGLT2 inhibitor for diabetic kidney disease (DKD) or left ventricular hypertrophy (LVH)
  10. Severe heart failure defined as equivalent to the New York Heart Association grade 3 (NYHA)
  11. Current treatment with anti-obesity drugs
  12. Learning difficulties that would prevent engagement with the program
  13. Having required hospitalization for depression or being prescribed antipsychotic drugs
  14. Known cancer
  15. Active substance misuse
  16. Contraindications to exercise
  17. Contraindications to lose weight
  18. Mental or physical incapacity that makes self-management inappropriate
  19. Pregnant, planning a pregnancy or lactating
  20. Currently undergoing palliative care
  21. Previous bariatric surgery or on waiting list for bariatric surgery (unless willing to come off waiting list)
  22. Unable to commit to long term lifestyle change
  23. Known proliferative retinopathy that has not been treated

Trial design

217 participants in 1 patient group

Low Energy Diet Group
Description:
A low energy diet comprising of three options and lifestyle modifications as part of a digitally enabled weight loss program.
Treatment:
Other: Option 3
Other: Option 2
Other: Option 1

Trial contacts and locations

4

Loading...

Central trial contact

Kristen S DeLuca

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems